TAW and AMAL to merge into a mid-tier Lithium provider. Few pros and cons being discussed on the forum. I'm pretty positive about it:
1) Exposure to the SGX (it will be the only listed lithium play) + a wider pool of Asian investors
2) The extra money from placements + synergies derived from the merger will allow TAW to expand quicker
It's my broader view that the near-term Li plays are the ones to watch and hold; any company with a product-to-market horizon beyond 2019 runs the risk of the existing players cutting their lunch by ramping up production and securing the most profitable contracts.
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: Tues 3rd Apr
TAW and AMAL to merge into a mid-tier Lithium provider. Few pros...
-
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add XAO (ASX) to my watchlist
(20min delay)
|
|||||
Last
8,515.2 |
Change
-3.700(0.04%) |
Mkt cap ! n/a |
Open | High | Low |
8,518.9 | 8,518.9 | 8,469.9 |
Featured News
XAO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online